Relay Therapeutics, Inc. (RLAY)
After hours:
| Previous close | 20.19 |
| Open | 20.07 |
| Bid | 22.00 x 800 |
| Ask | 22.61 x 1100 |
| Day's range | 20.07 - 22.02 |
| 52-week range | 12.65 - 35.36 |
| Volume | |
| Avg. volume | 1,331,936 |
| Market cap | 2.645B |
| Beta (5Y monthly) | 1.01 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -3.85 |
| Earnings date | 22 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 36.20 |
- Zacks
Relay Therapeutics, Inc. (RLAY) Soars 20.7%: Is Further Upside Left in the Stock?
Relay Therapeutics, Inc. (RLAY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- GlobeNewswire
Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 2:15 p.m. PT. The presentation will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events s
- Simply Wall St.
Relay Therapeutics, Inc.'s (NASDAQ:RLAY) Intrinsic Value Is Potentially 23% Below Its Share Price
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Relay Therapeutics...
